No Data
No Data
Pharma Stocks Have Risk of U.S. Tariffs Priced In -- Market Talk
Barclays Sticks to Its Buy Rating for AstraZeneca (AZN)
Top Gap Ups and Downs on Monday: AZN, NVS, UL and More
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading
AstraZeneca (AZN) Gets a Hold From Deutsche Bank
Conduit Pharmaceuticals Expands Partnership With Sarborg To Apply Advanced Machine Learning Analysis On Clinical Data From AstraZeneca-Acquired Assets, Aiming To Uncover New Insights And Optimize Development Pathways For AZD1656, AZD5658, And AZD5904